Advertisement
Advertisement

PTCT

PTCT logo

PTC Therapeutics, Inc.

42.97
USD
+2.68
+6.65%
Apr 11, 15:59 UTC -4
Closed
exchange

After-Market

42.99

+0.02
+0.05%

PTC Therapeutics, Inc. Profile

About

PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.

Info & Links

CEO

Matthew B. Klein

Headquarters

500 WARREN CORPORATE CENTER DRIVE
WARREN, NJ 07059, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.ptcbio.com

Auditor

Ernst & Young LLP

Share holders

78

Employees

939

PTC Therapeutics, Inc. Statistics

Valuation Measures

Market Capitalization2

3.32B

Enterprise Value

4.92B

Enterprise Value/EBITDA(ttm)

-62.55

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

4.31

Price to Book(mrq)

--

Price to Cash(ytd)

20.80

Profitability

Gross Margin(ttm)

92.88%

Operating Margin(ttm)

-33.97%

Profit Margin(ttm)

-45.45%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-34.00%

Return on Assets(ttm)

-16.44%

Income Statement

Revenue(ttm)

806.78M

Revenue Per Share(ttm)

10.23

Gross Profit(ttm)

749.38M

EBITDA(ttm)3

-78.69M

Net Income Available to Common(ttm)

-363.29M

Diluted EPS(ttm)

-5.94

Share Statistics

Beta (5Y Monthly)

0.62

52-Week Change

62.64%

S&P 500 52-Week Change

5.96%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

78.87M

Dividend Yield

0.00%

Float4

72.88M

% Held by Insiders

5.50%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

1.14B

Total Cash Per Share(mrq)

14.45

Total Debt(mrq)

2.39B

Total Debt/Equity(mrq)

-217.27%

Current Ratio(mrq)

2.35%

Quick Ratio(mrq)

2.04%

Book Value Per Share(mrq)

-14.13

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.40

Free Cash Flow(ytd)

-86.13M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement